← Leaderboards
Daniel Mark Lipinski
Medical College Of Wisconsin
$3,118,530
Attributed
$4,412,390
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,412,390 · 2
By mechanism
R01$4,412,390 · 2
Top collaborators
- Andras Komaromy4 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Elena V Semina$12,663,827
- Jeffrey R Binder$14,895,817
- Matthew Robert Hodges$8,259,502
- Reza Shaker$77,917,775
- Thomas Jay Ebert$977,201
Others in their field
Other Emerging Leaders on “Publications”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- John E West · University Of Texas At Austin$127,816,494
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Klaus Romero · Critical Path Institute$86,053,372
- Peter K Fritschel · California Institute Of Technology$78,820,000
Research focus
PublicationsPreventDesignFutureOptical Coherence TomographyOperative Surgical ProceduresClinically RelevantClinical TrialsDoseFunctional DisorderLaboratoriesLasersMediatingMedical SchoolsAdeno-Associated Viral VectorCellsClinical ManagementClinical TranslationAbbreviationsDisease ProgressionEarly DiagnosisBlindnessGene TherapyRecombinant Adeno-Associated Virus (Raav)
Grant awards (9)
Development of an IOP-lowering gene therapy treatment for glaucoma$629,806
R01 · FY2025 · EY · contact PI
Development of an IOP-lowering gene therapy treatment for glaucoma$644,048
R01 · FY2024 · EY · contact PI
Development of an IOP-lowering gene therapy treatment for glaucoma$638,374
R01 · FY2023 · EY · contact PI
Development of an IOP-lowering gene therapy treatment for glaucoma$675,492
R01 · FY2022 · EY · contact PI
Vascular Gene Delivery and Early Disease Biomarkers in Diabetic Retinopathy$360,314
R01 · FY2022 · EY · contact PI
Vascular Gene Delivery and Early Disease Biomarkers in Diabetic Retinopathy$360,868
R01 · FY2021 · EY · contact PI
Vascular Gene Delivery and Early Disease Biomarkers in Diabetic Retinopathy$372,584
R01 · FY2020 · EY · contact PI
Vascular Gene Delivery and Early Disease Biomarkers in Diabetic Retinopathy$358,060
R01 · FY2019 · EY · contact PI
Vascular Gene Delivery and Early Disease Biomarkers in Diabetic Retinopathy$372,844
R01 · FY2018 · EY · contact PI